PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. (Q53255741)
Jump to navigation
Jump to search
scientific article published on 6 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. |
scientific article published on 6 April 2011 |
Statements
PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. (English)
1 reference
Martin A Cheever
1 reference
Celestia S Higano
1 reference
6 April 2011
1 reference
17
1 reference
11
1 reference
3520-3526
1 reference
Identifiers
1 reference